Therapeutic use of Aldara™ in chronic myeloid leukemia
<p>Abstract</p> <p>The potent clinical responses seen in patients with chronic myeloid leukemia (CML) after administration of donor-specific lymphocytes, as well as the correlation between the presence of antigen specific T cells and prolonged remission in these patients, suggests...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-01-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/5/1/4 |